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with SleepA new study in fruit flies suggests modulation of neural activity links sleep and
Alzheimer’s disease. Both sleep loss and amyloid beta increase neural
excitability, which reinforces the accumulation of amyloid beta and shortens
lifespan.Alex C. Keene1,*
and William J. Joiner2
Alzheimer’s disease (AD) is a
progressive, irreversible brain disorder
that gradually erodes neural circuits
underlying higher order cognitive
functions including learning and
memory. It is the most common
neurodegenerative disorder of the
elderly, afflicting over 35 million people
worldwide [1]. Due to the absence of
effective treatment options it is
inevitably fatal. Thus, there is great
interest in understanding the molecular
and neural circuit changes that
accompany AD, especially during its
onset. An intriguing hypothesis [2],
testedmost recently by Tabuchi et al. in
this issue of Current Biology [3], is that
AD and poor quality sleep may be
mutually enforcing, with overlap in the
underlying dysfunctional mechanisms
of control.
The brains of healthy, aging adults
are subjected to various stressors that
are thought to increase the likelihood of
subsequent neural degeneration and
dementia. Mounting evidence
suggests a primary factor in AD
pathogenesis is accumulation of
amyloid beta (Ab) protein within the
brain. For example, heritable forms of
AD are caused by mutations in a
genetic precursor of Ab called APP or
in genes called presenilins, whose
protein products process APP to Ab.
The risk of developing AD is also
increased by certain alleles of the
gene encoding apolipoprotein E, which
may regulate clearance of Ab [4].
Evidence suggests that an imbalancebetween clearance and production
of Ab results in toxic amyloid
aggregates within neurons or as
plaques between neurons that initially
damage synapses and later cause
neurodegeneration [5].
Several factors are known to
modulate the toxicity of Ab, and one of
these is sleep. For example, in a mouse
model of AD, knockout of the
wake-promoting orexin gene reduces
Ab accumulation, an effect that is
reversed by sleep deprivation [6]. In
humans as well, the risk of
accumulating Ab is decreased by
consolidated sleep, whereas the risk of
developing certain forms of AD is
enhanced by poor quality sleep.
Intriguingly, insomnia is common
among patients with AD, and the
severity of this symptom is correlated
with the degree of dementia [7].
Collectively this evidence has led to the
hypothesis that AD and sleep have a
bidirectional relationship that could
inform understanding of both disorders
and lead to improved treatment options
for AD [2].
The fruit fly, Drosophila
melanogaster, provides a powerful
model system for investigating both
neurodegenerative disease and sleep.
Flies expressing humanAb recapitulate
several key features of AD, including
Ab accumulation, age-dependent
learning impairment, and
neurodegeneration [8]. Drosophila also
show all the hallmarks of sleep in
vertebrates, including elevated arousal
threshold, homeostatic control, and
electrophysiological distinction from
wakefulness [9]. Although themechanistic relationship between AD
and sleep has eluded researchers,
Tabuchi et al. [3] suggest that both
phenomena may influence each other
by altering neuronal activity (Figure 1).
To examine the reciprocal relationship
between AD and sleep in flies, the
authors expressed different forms of
Ab throughout the nervous systems of
flies. They found that Ab reduced sleep,
but only when it was expressed in
pathogenic forms, especially a variant
called Arctic, which encodes a
membrane-tethered mutant form of
human Ab with enhanced toxicity [10].
It is common for AD patients to have
reduced or disrupted sleep as well,
supporting the possibility that Ab
suppresses sleep but also raising the
additional possibility that poor quality
sleep promotes the accumulation of
Ab. To test the latter hypothesis in flies,
the authors measured Ab levels
following expression of Arctic in the
mushroombodies (MBs), a brain region
required for many types of associative
memory. Sleep deprivation following
mechanical perturbation or
thermogenetic activation of
dopaminergic neurons increased Ab
levels, and sleep induction by
activation of arousal-suppressing
neurons decreased Ab levels.
Collectively these data suggest that
waking interferes with and sleep
facilitates clearance of Ab from the
brain. These experiments also support
mammalian studies suggesting that
sleep functions to rid the brain of
metabolic wastes, including Ab [11].
Although the cellular roles of both
sleep and Ab remain poorly
understood, sleep appears tomodulate
synaptic strength across phyla. Studies
in flies and rodents reveal the
brain-wide accumulation of markers of
synaptic potentiation during
wakefulness which appear to dissipate
during sleep [12,13]. These findings
support another leading hypothesis
about sleep, which is that it facilitates
synaptic depression to counterbalance
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Figure 1. A model for the effects of sleep deprivation and neural activity on Ab accumulation.
Both sleep deprivation and transgenic expression of Ab increase neural activity. Additionally,
transgenic Ab expression reduces sleep. The effects of Ab expression on neural activity
and sleep are rescued by feeding flies the anti-convulsant levetiracetam (LEV). LEV extends
lifespan in Ab-expressing flies but the effects on sleep have not been tested.
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R235net potentiation during waking and
thus maintains overall homeostasis of
synaptic strength across the brain [12].
If this were true then sleep’s ability to
suppress Ab accumulation might be
caused by a reduction in neuronal
excitability, which would reduce
synaptic activity. Consistent with this
idea, neuronal activity positively
regulates Ab accumulation inmammals
[14–17], and indeed Tabuchi et al.
found that electrically silencing MBs
with a transgenic potassium channel
overcame the ability of sleep
deprivation to elevate Ab levels in the
MBs. Thus, neuronal excitability acts
downstream of sleep to regulate Ab
accumulation. This principle held up
even when sleep was induced by
activating arousal-suppressing
neurons with a transgenic sodium
channel: increasing excitability of these
neurons overcame the ability of sleep
to reduce Ab levels in the same cells.
To determine if sleep normally
regulates neuronal excitability,
Tabuchi et al. then recorded from
the large ventral lateral neurons (lLNvs)
that regulate circadian behavior and
sleep in flies. When synaptic
transmission was blocked to isolate
intrinsic excitability, the researchers
found that the firing frequencies of
lLNvs were elevated by sleep
deprivation. Similar results were
obtained in the absence of sleep
deprivation when Arctic was expressed
in the same neurons. Thus, both
sleep deprivation and Ab increase
neuronal excitability. The authors then
isolated individual currents in the same
neurons at membrane potentials
around threshold, where firing
frequency is most likely to be affected.
They found that a potassium
current was reduced by sleep
deprivation alone, and another
potassium current was additionally
reduced when sleep deprivation was
combined with Arctic expression.
Thus, sleep deprivation and Ab
converge mechanistically by
decreasing potassium currents to
increase neuronal excitability, which in
turn may interfere with Ab clearance.
Based on these findings, Tabuchi
et al. then reasoned that, like sleep,
pharmacological reduction of neuronal
activity might also reduce Ab
accumulation. To test this hypothesis
they fed flies the anti-convulsant
levetiracetam (LEV). Strikingly,
treatment with LEV reduced Ab levels
and improved longevity in Arctictransgenic flies, while having no
noticeable effect on controls,
suggesting that LEV protects against
Ab-induced toxicity. These results led
the authors to propose that sleep loss
and Ab function in a positive feedback
loop to potentiate each other’s
influence on hyperexcitability, which in
turn interferes with Ab clearance.
Although previous mammalian
studies have correlated either
Ab-induced alterations with increased
excitability or sleep changes with AD
pathology, Tabuchi et al. provide a
mechanistic link between all four
phenomena. While these authors
provide evidence for cell-autonomous
accumulation of Ab in neurons that is
linked to sleep deprivation, other
factors likely regulate Ab buildup as
well. For example, in mice, evidence
suggests the sleep facilitates the
removal of metabolic wastes by the
brain’s glymphatic system, an effectthat extends to injected Ab as well [11].
Furthermore, in mammals, Ab
plaques are found within and
between neurons and therefore
are unlikely to be governed
exclusively by the cell-autonomous
mechanisms described here. It is
possible that Ab accumulation is
regulated by both cell-autonomous
and systemic mechanisms, or
that different regulatory mechanisms
exist in flies and mammals.
Addressing these questions in
mammals will be important for
understanding the applicability of the
current findings to human disease
etiology.
Another question raised by this study
is whether treatment options for AD
should be considered that focus on
modulation of neuronal activity.
Current therapies are largely palliative
and attempt to boost signaling of
nondegenerated synpases, whereas
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medications have been focused on
ways to reduce levels of toxic Ab [1].
With respect to the latter it is notable
that several Ab-induced alterations
have been recapitulated in wild-type
mice following seizure induction or
prevented in an AD mouse model by
blocking overexcitation, thus
supporting a role for neuronal
hyperactivity in AD symptomology [18].
Surprisingly, among various
anti-epileptics that have been tested
head-to-head in a mouse model of AD,
only LEV reduced hyperexcitability,
remodeling of hippocampal circuits,
synaptic dysfunction, and cognitive
deficits [19]. It will thus be important to
determine why LEV is more effective
than other suppressors of neuronal
activity at reducing AD symptomology
and how exactly this drug mediates its
effects. While attempts to slow
neurodegeneration in AD patients have
met little success, the finding that sleep
loss and neural excitability may
underlie Ab accumulation in the fruit fly
paves the way for new approaches to
drug development.
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Suffer ‘False Memories’The existence of ‘falsememories’, where individuals remember events that they
have never actually experienced, is well established in humans. Now a new
study reports that insects similarly form illusory memories through merging
of memory traces.Judith Reinhard
Memories define us as individuals. We
accumulate them throughout our lives,
lay some of them down as long-term
memories that last a life-time, while
other memories are short-lived and
only last for minutes or days. Although
we tend to believe that our memories
are precise recollections of past
events, memories are a fickle thing.No two people have the exact same
memories even if they experience
the same events, which is why eye
witness records are notoriously
unreliable. Memories may change
over time as the brain recalls and
re-consolidates them, resulting in
various types of ‘false memories’,
where individuals remember events
or objects that they have never actually
been exposed to or merge differentmemory traces into an illusory memory
[1–3]. For example, when presented
with a list of words all pertaining to fruit,
people would remember the word
‘apple’ even if it was not on the list.
While the existence of such memory
errors is well established in humans
[2,3], it has never before been shown
in animals, although many animal
species from insects to vertebrates
are known for their sophisticated
learning and memory abilities. Now,
a new study by Kate Hunt and Lars
Chittka [4], published in this issue
of Current Biology, has revealed
that an insect with a small brain, the
bumble bee, also suffers false
memories. The study suggests that
memory traces for different visual
stimuli such as a colour and a
black-and-white pattern are merged
